Breaking News

You are here » Indian-Commodity  :  Corporate  :  GoI to infuse Rs 3,004 crore in SBI by March


GoI to infuse Rs 3,004 crore in SBI by March

State Bank of India (SBI) has received approval from central board of the bank for infusion of Capital funds in the Bank by the Government of India (GoI), to the tune of Rs 3004 crore during FY 2012-13, by way of preferential allotment of equity shares to the GoI, to enable the Bank to support national and international banking operations undertaken through its subsidiaries and associates. In this connection, the Bank is seeking necessary approvals from RBI and GoI under section 5(2) of the State Bank of India Act to increase its issued capital.

Last fiscal, the government had infused Rs 7,900 crore in SBI to increase the Tier-I capital of the country's largest bank. Following the capital infusion in March 2012, the government holding in SBI rose to 61.58% from 59.4%.

In FY11-12, the government pumped in about Rs 12,000 crore additional in public sector banks as against Rs 20,117 crore in 2010-11.

Related News

View all news

CARE revises ratings of Essar Oil's bank facilities

Credit rating agency, CARE has revised rating of Essar Oil's long term bank facilities worth Rs 9077.58 crore to 'A' from 'A-'. The rating agency has also revised rating of company's short term bank facilities......

PTC India inks MoU with South Delhi Municipal Corporation

PTC India has inked Memorandum of Understanding (MoU) with South Delhi Municipal Corporation for adoption of part of Bhikaji Cama Place under its 'Swachh Bharat Abhiyan'. As per the MOU, the company will......

KPR Mill to increase its manufacturing capacity to 95 million garments per annum

KPR Mill has performed Bhoomi pooja at Thekkalur near Tirupur on September 01, 2015 for its new state of the art manufacturing facility of 36 million garments capacity. On its establishment, which is expected......

Top News

View all news

Lupin, Tata Steel, Cipla and NBCC to see some action today

Lupin Pharmaceuticals, a subsidiary of Lupin, has launched its Duloxetine 40 mg Delayed-Release (DR) Capsule, which is the first and only generic Duloxetine formulation to become available in 40 mg dosage......

Near-term growth prospects remain favourable in India: IMF

International Monetary Fund (IMF) in its report 'Global prospects and policy challenges', meant for the G20 meeting of finance ministers in Ankara has stated that near-term growth prospects remain favourable......

HDFC Bank, ITC, Infosys and Syngene International to see some action

HDFC Bank, India's second largest private bank, cut its base rate by 35 basis points to 9.35%, from the existing 9.70 percent, thereby making loans from the bank cheaper. Earlier in June, the bank had......